3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure

Details for Australian Patent Application No. 2002305416 (hide)

Owner Allergan, Inc.

Inventors Posner, Mari, F.; Burk, Robert, M.; Holoboski, Mark

Agent Davies Collison Cave

Pub. Number AU-B-2002305416

PCT Number PCT/US02/14331

PCT Pub. Number WO2002/089813

Priority 09/851,296 08.05.01 US

Filing date 6 May 2002

Wipo publication date 18 November 2002

Acceptance publication date 10 January 2008

International Classifications

A61K 31/5575 (2006.01)

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07C 405/00 (2006.01) Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 09/851,296 08.05.01 US

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002305416

10 January 2008 Application Accepted

  Published as AU-B-2002305416

8 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002305417-SULFONAMIDES

2002305415-SUPPORT STRUCTURE AND METHOD OF ASSEMBLY THEREOF